Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

The role of LAT1 in (18)F-DOPA uptake in malignant gliomas.

Youland RS, Kitange GJ, Peterson TE, Pafundi DH, Ramiscal JA, Pokorny JL, Giannini C, Laack NN, Parney IF, Lowe VJ, Brinkmann DH, Sarkaria JN.

J Neurooncol. 2013 Jan;111(1):11-8. doi: 10.1007/s11060-012-0986-1. Epub 2012 Oct 20.

3.

Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET.

Wiriyasermkul P, Nagamori S, Tominaga H, Oriuchi N, Kaira K, Nakao H, Kitashoji T, Ohgaki R, Tanaka H, Endou H, Endo K, Sakurai H, Kanai Y.

J Nucl Med. 2012 Aug;53(8):1253-61. doi: 10.2967/jnumed.112.103069. Epub 2012 Jun 28.

4.

Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.

Kobayashi K, Ohnishi A, Promsuk J, Shimizu S, Kanai Y, Shiokawa Y, Nagane M.

Neurosurgery. 2008 Feb;62(2):493-503; discussion 503-4. doi: 10.1227/01.neu.0000316018.51292.19.

PMID:
18382329
5.

Correlation of L-methyl-11C-methionine (MET) uptake with L-type amino acid transporter 1 in human gliomas.

Okubo S, Zhen HN, Kawai N, Nishiyama Y, Haba R, Tamiya T.

J Neurooncol. 2010 Sep;99(2):217-25. doi: 10.1007/s11060-010-0117-9. Epub 2010 Jan 21.

PMID:
20091333
6.

Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.

Pafundi DH, Laack NN, Youland RS, Parney IF, Lowe VJ, Giannini C, Kemp BJ, Grams MP, Morris JM, Hoover JM, Hu LS, Sarkaria JN, Brinkmann DH.

Neuro Oncol. 2013 Aug;15(8):1058-67. doi: 10.1093/neuonc/not002. Epub 2013 Mar 3.

7.

L-type amino acid transporter-1 expressed in human astrocytomas, U343MGa.

Asano S, Kameyama M, Oura A, Morisato A, Sakai H, Tabuchi Y, Chairoungdua A, Endou H, Kanai Y.

Biol Pharm Bull. 2007 Mar;30(3):415-22.

8.

Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells.

Kim DK, Kanai Y, Choi HW, Tangtrongsup S, Chairoungdua A, Babu E, Tachampa K, Anzai N, Iribe Y, Endou H.

Biochim Biophys Acta. 2002 Sep 20;1565(1):112-21.

9.

Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.

Lapa C, Linsenmann T, Monoranu CM, Samnick S, Buck AK, Bluemel C, Czernin J, Kessler AF, Homola GA, Ernestus RI, Löhr M, Herrmann K.

J Nucl Med. 2014 Oct;55(10):1611-6. doi: 10.2967/jnumed.114.140608. Epub 2014 Aug 14.

10.

Value of 18F-3,4-dihydroxyphenylalanine PET/MR image fusion in pediatric supratentorial infiltrative astrocytomas: a prospective pilot study.

Morana G, Piccardo A, Milanaccio C, Puntoni M, Nozza P, Cama A, Zefiro D, Cabria M, Rossi A, Garrè ML.

J Nucl Med. 2014 May;55(5):718-23. doi: 10.2967/jnumed.113.125500. Epub 2014 Mar 20.

11.

Biological significance of fluorine-18-α-methyltyrosine (FAMT) uptake on PET in patients with oesophageal cancer.

Suzuki S, Kaira K, Ohshima Y, Ishioka NS, Sohda M, Yokobori T, Miyazaki T, Oriuchi N, Tominaga H, Kanai Y, Tsukamoto N, Asao T, Tsushima Y, Higuchi T, Oyama T, Kuwano H.

Br J Cancer. 2014 Apr 15;110(8):1985-91. doi: 10.1038/bjc.2014.142. Epub 2014 Mar 25.

12.

¹⁸F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas.

Hirata K, Terasaka S, Shiga T, Hattori N, Magota K, Kobayashi H, Yamaguchi S, Houkin K, Tanaka S, Kuge Y, Tamaki N.

Eur J Nucl Med Mol Imaging. 2012 May;39(5):760-70. doi: 10.1007/s00259-011-2037-0. Epub 2012 Feb 4.

PMID:
22307533
13.

Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study.

Kaira K, Oriuchi N, Otani Y, Shimizu K, Tanaka S, Imai H, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Dobashi K, Kanai Y, Endou H, Nakajima T, Endo K, Mori M.

Clin Cancer Res. 2007 Nov 1;13(21):6369-78.

14.

Diagnostic usefulness of ¹⁸F-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma.

Nobusawa A, Kim M, Kaira K, Miyashita G, Negishi A, Oriuchi N, Higuchi T, Tsushima Y, Kanai Y, Yokoo S, Oyama T.

Eur J Nucl Med Mol Imaging. 2013 Oct;40(11):1692-700. doi: 10.1007/s00259-013-2477-9. Epub 2013 Jun 26.

PMID:
23801167
15.

Preclinical characterization of 18F-D-FPHCys, a new amino acid-based PET tracer.

Denoyer D, Kirby L, Waldeck K, Roselt P, Neels OC, Bourdier T, Shepherd R, Katsifis A, Hicks RJ.

Eur J Nucl Med Mol Imaging. 2012 Apr;39(4):703-12. doi: 10.1007/s00259-011-2017-4. Epub 2011 Dec 13.

PMID:
22160176
16.

Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas.

Fueger BJ, Czernin J, Cloughesy T, Silverman DH, Geist CL, Walter MA, Schiepers C, Nghiemphu P, Lai A, Phelps ME, Chen W.

J Nucl Med. 2010 Oct;51(10):1532-8. doi: 10.2967/jnumed.110.078592. Epub 2010 Sep 16.

17.

5-(2-18F-fluoroethoxy)-L-tryptophan as a substrate of system L transport for tumor imaging by PET.

Krämer SD, Mu L, Müller A, Keller C, Kuznetsova OF, Schweinsberg C, Franck D, Müller C, Ross TL, Schibli R, Ametamey SM.

J Nucl Med. 2012 Mar;53(3):434-42. doi: 10.2967/jnumed.111.096289. Epub 2012 Feb 13.

18.

Imaging the L-type amino acid transporter-1 (LAT1) with Zr-89 immunoPET.

Ikotun OF, Marquez BV, Huang C, Masuko K, Daiji M, Masuko T, McConathy J, Lapi SE.

PLoS One. 2013 Oct 15;8(10):e77476. doi: 10.1371/journal.pone.0077476. eCollection 2013.

19.

L-type amino acid transporter 1 (LAT1) expression in canine mammary gland tumors.

Fukumoto S, Hanazono K, Komatsu T, Iwano H, Kadosawa T, Uchide T.

J Vet Med Sci. 2013 May 2;75(4):431-7. Epub 2012 Nov 22.

20.

Preferred transport of O-(2-[18F]fluoroethyl)-D-tyrosine (D-FET) into the porcine brain.

Makrides V, Bauer R, Weber W, Wester HJ, Fischer S, Hinz R, Huggel K, Opfermann T, Herzau M, Ganapathy V, Verrey F, Brust P.

Brain Res. 2007 May 25;1147:25-33. Epub 2007 Feb 9.

PMID:
17343835
Items per page

Supplemental Content

Write to the Help Desk